[
    [
        {
            "time": "",
            "original_text": "国信医药】乐普医疗：器械增长提速，业绩符合预期（三季报点评）",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "器械",
                    "增长提速",
                    "业绩",
                    "三季报"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国信医药】乐普医疗：器械增长提速，业绩符合预期（三季报点评）",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "外资持仓最新动向：QFII新进36股，陆股通增持银行、地产",
            "features": {
                "keywords": [
                    "外资",
                    "QFII",
                    "陆股通",
                    "增持",
                    "银行",
                    "地产"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "银行",
                    "地产"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "外资持仓最新动向：QFII新进36股，陆股通增持银行、地产",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华泰医药代雯团队】乐普医疗（300003.SZ）三季报点评：稳健依旧，昂首前行",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "华泰医药",
                    "三季报",
                    "稳健",
                    "昂首前行"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华泰医药代雯团队】乐普医疗（300003.SZ）三季报点评：稳健依旧，昂首前行",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "乐普医疗2019年三季报点评:内生利润保持超30%较高增长,耗材集采不必过于悲观",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "三季报",
                    "内生利润",
                    "30%增长",
                    "耗材集采",
                    "悲观"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗2019年三季报点评:内生利润保持超30%较高增长,耗材集采不必过于悲观",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]